Related Experiment Video
Updated: Sep 11, 2025
Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
G-Protein-Coupled Receptor Class C Group 6 Member A (GPRC6A) and Serine Protease Inhibitor, Kazal Type 1 (SPINK1)
Sakura Higashida1, Seiji Futagami1, Ken Nakamura1
1Division of Gastroenterology, Nippon Medical School, Tokyo, JPN.
Background:
This study aims to determine the associations between single-nucleotide polymorphisms (SNPs) in G-protein-coupled receptor class C group 6 member A (GPRC6A) and serine protease inhibitor, Kazal type 1 (SPINK1) genes and the clinical characteristics, including clinical symptoms, pancreatic enzyme abnormalities, and exocrine pancreatic function, with refractory functional dyspepsia (R-FD).
Methods:
Around 97 patients with FD and 74 R-FD were recruited. Five pancreatic enzymes were measured. DNA was isolated from blood or duodenal tissues. Endoscopic ultrasonography (EUS) was performed using Olympus EUS (GF-UCT 260; Olympus, Tokyo, Japan) under conscious sedation in patients with R-FD. Exocrine or endocrine pancreatic function was estimated.
Results:
Significant differences (p < 0.001) were observed in the ratio of abnormal pancreatic enzyme levels between patients with R-FD and those with FD. However, no significant differences in the distribution of GPRC6A and SPINK1 genotypes were observed in the FD and R-FD groups. EUS score in the GG genotype was significantly higher than in the CC or CG genotypes (p = 0.036 and p = 0.031, respectively) in GPRC6A in R-FD. In addition, the lobularity in GG genotype in GPRC6A in R-FD was also significantly higher (p = 0.023 and p = 0.027, respectively) than that in CC or CG.
Conclusion:
Significant differences (p < 0.001) were observed in the ratio of abnormal pancreatic enzyme levels between patients with R-FD and those with FD. GPRC6A genotype was significantly associated with EUS features, and further studies will be needed to clarify the significant association between GPRC6A genotype and EUS score.
Related Concept Videos
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:29Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:26Endoscopic Procedures V: ERCP
Patient...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: